<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03040505</url>
  </required_header>
  <id_info>
    <org_study_id>6527</org_study_id>
    <nct_id>NCT03040505</nct_id>
  </id_info>
  <brief_title>Future Mental Projections in Schizophrenia</brief_title>
  <acronym>FutureProSchiz</acronym>
  <official_title>Future Mental Projections in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate temporal organization of future thinking in patients&#xD;
      with schizophrenia. Patients and control participants will be asked to envision and briefly&#xD;
      describe ten personal future events using a cue-words list. Then they will be asked to&#xD;
      describe everything that came to their minds (i.e. to think aloud) while they attempted to&#xD;
      determine when an event will likely occur. The investigators will compare the proportion of&#xD;
      several predefined strategies mentioned by the two groups of participants to locate future&#xD;
      events in time. The investigators predict that patients will envision less personal future&#xD;
      events and will rely to a lesser extent on strategies to locate events in time, than control&#xD;
      participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">April 5, 2017</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of time location strategies</measure>
    <time_frame>1 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
    <description>Patients with schizophrenia or schizoaffective disorder according to DSM-V criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control participants</arm_group_label>
    <description>- Control participants without psychiatric nor neurological history</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnary</intervention_name>
    <description>Participant's verbalization will be audio recorded and then transcribed by investigators. The investigators will use predefined categories to score the strategies mentioned by participants during the think aloud task.</description>
    <arm_group_label>Control participants</arm_group_label>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with Schizophrenia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  for patients only&#xD;
&#xD;
          -  male or female&#xD;
&#xD;
          -  age limits : 18-55 years old&#xD;
&#xD;
          -  under the protection of health insurance&#xD;
&#xD;
          -  who have signed up the consent form&#xD;
&#xD;
          -  schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA,&#xD;
             2013).&#xD;
&#xD;
          -  clinically stable for at least 2 months&#xD;
&#xD;
          -  patients under guardianship or curatorship need agreement of their legal&#xD;
             representative&#xD;
&#xD;
          -  informed of the results of prior medical examination for controls only&#xD;
&#xD;
          -  male or female&#xD;
&#xD;
          -  age limits : 18-55 years old&#xD;
&#xD;
          -  under the protection of health insurance&#xD;
&#xD;
          -  who have sign up the consent form&#xD;
&#xD;
          -  recruited from the general population and matched on gender, age years of schooling&#xD;
&#xD;
          -  no psychiatric history (DSM-5)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  for both patients and controls&#xD;
&#xD;
          -  current severe or unstable somatic illness&#xD;
&#xD;
          -  neurological history (brain injury &gt; 15 minutes loss of consciousness , epilepsia,&#xD;
             brain surgeryâ€¦)&#xD;
&#xD;
          -  current substance use disorder (DSM-5)&#xD;
&#xD;
          -  current major depressive disorder (CDSS,BDI, HDRS)&#xD;
&#xD;
          -  mental retardation (IQ &lt; 70, WAIS-4, f-NART)&#xD;
&#xD;
          -  history of general anesthesia 3 months prior to the experiment&#xD;
&#xD;
          -  pregnancy declared by the subject&#xD;
&#xD;
          -  breast feeding&#xD;
&#xD;
          -  current legal control&#xD;
&#xD;
          -  in emergency situation&#xD;
&#xD;
          -  included during exclusion period in another experiment&#xD;
&#xD;
          -  for controls only&#xD;
&#xD;
          -  taking of antipsychotic drugs for the 3 weeks prior to inclusion&#xD;
&#xD;
          -  under guardianship or curatorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabrice BERNA, MD</last_name>
    <phone>0033388116462</phone>
    <email>fabrice.berna@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de psychiatrie 1</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Berna</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 27, 2017</study_first_submitted>
  <study_first_submitted_qc>January 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2017</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

